Discovery of tetralin carboxamide growth hormone secretagogue receptor antagonists via scaffold manipulation.

J Med Chem

Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-6098, USA.

Published: December 2004

A case study of rational design of an efficient, specific, and proprietary molecular scaffold based on the structure-activity relationship (SAR) information on a screening hit is described. Potent, selective, and orally bioavailable tetralin carboxamide growth hormone secretagogue receptor (GHS-R) antagonists were discovered. Union of rational design and high throughput synthesis provided a quick access to high quality chemical leads.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm0491750DOI Listing

Publication Analysis

Top Keywords

tetralin carboxamide
8
carboxamide growth
8
growth hormone
8
hormone secretagogue
8
secretagogue receptor
8
rational design
8
discovery tetralin
4
receptor antagonists
4
antagonists scaffold
4
scaffold manipulation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!